Am Heart J
- HERBERT BM, Carson JL, Bertolet M, Alexander JH, et al
A Comprehensive Set of Per-Protocol Analyses of the Myocardial Ischemia and
Transfusion (MINT) Trial.
Am Heart J. 2026 Feb 18:107382. doi: 10.1016/j.ahj.2026.107382.
Ann Intern Med
- KELSEY MD
In patients with CAD, clopidogrel vs. aspirin monotherapy reduces MACCE without
increasing major bleeding.
Ann Intern Med. 2026;179:JC16.
Catheter Cardiovasc Interv
- ROH KH, Kim YH, Choo EH, Lee KY, et al
The Prognostic Impact of Multiple Adverse Events on Long-Term Mortality Following
Acute Myocardial Infarction.
Catheter Cardiovasc Interv. 2026 Feb 18. doi: 10.1002/ccd.70521.
Circ Cardiovasc Imaging
- QI J, Yue X, Hu M, Cui J, et al
Synthetic Contrast-Free LGE via Diffusion-Based Framework in Acute MI for Image
Quality and Quantitative Scar Analysis.
Circ Cardiovasc Imaging. 2026;19:e018967.
- TOPRICEANU CC, Webber M, Shiwani H, Chan F, et al
Higher Life-Course Blood Pressure Associates With Reduced Myocardial Perfusion in
Older Age: Insights From MyoFit46.
Circ Cardiovasc Imaging. 2025 Nov 8:e019105. doi: 10.1161/CIRCIMAGING.125.019105
Circ Cardiovasc Interv
- RYMER JA, Li S, Chiswell K, Smilowitz NR, et al
Impact of In-Hospital STEMI on Reperfusion Times and Clinical Outcomes.
Circ Cardiovasc Interv. 2026;19:e015547.
- MANSOOR H, Young R, Kaltenbach LA, Wojdyla DM, et al
Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription
Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI
Registry.
Circ Cardiovasc Interv. 2026;19:e015600.
- LOUCA A, Petursson P, Sundstrom J, Hagstrom H, et al
PCI Versus Conservative Management Before TAVR in Patients With Significant
Coronary Artery Disease: A Nationwide Instrumental Variable Analysis.
Circ Cardiovasc Interv. 2026 Feb 20:e016337.
Circ Genom Precis Med
- TSAO NL, Abramowitz SA, Shakt GE, Judy R, et al
Angiographic Burden of Coronary Atherosclerosis Partially Mediates the
Association Between ASCVD Risk Factors and Outcomes.
Circ Genom Precis Med. 2026 Feb 20:e005266. doi: 10.1161/CIRCGEN.125.005266.
Circ Heart Fail
- MEHTA C, Has P, Mehta A, Vargas I, et al
Etiology, Management, and Outcomes of Society for Cardiovascular Angiography and
Interventions Stage B Cardiogenic Shock.
Circ Heart Fail. 2026 Feb 19:e013814. doi: 10.1161/CIRCHEARTFAILURE.125.013814.
Circulation
- BOYER TM, Barrett RB, Xiong C, Bu F, et al
Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a
Diverse Cohort of Young US Women.
Circulation. 2026;153:480-492.
- ROSEN SE
Redefining Cardiovascular Medicine: The Journey From "Does Sex Matter?" to "How
Does Sex Matter?".
Circulation. 2026;153:534-535.
- GRAGNANO F, Giacoppo D, Choi KH, Kimura T, et al
Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A
Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials.
Circulation. 2026;153:543-546.
- CARNETHON MR, Post WS, Hill JA, Al-Khatib SM, et al
Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of
Cardiovascular Disease.
Circulation. 2026;153:467-468.
Clin Cardiol
- BOND P, Smit DL, Verdegaal T, de Ronde W, et al
Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers.
Clin Cardiol. 2026;49:e70257.
Eur Heart J
- ZARAGOZA C
When RNAs come full circle: new regulators of healing after myocardial
infarction.
Eur Heart J. 2026 Feb 18:ehag038. doi: 10.1093.
Int J Cardiol
- JIN S, Liu W, Chen X, Guo W, et al
Caveolin-3 serves as a therapeutic target for myocardial ischemia-reperfusion
injury in cardiac surgery patients.
Int J Cardiol. 2026;449:134179.
- FEZZI S, Zhu Y, Bargary N, Ding D, et al
Predicting functional results of percutaneous coronary intervention using machine
learning modelling.
Int J Cardiol. 2026;449:134183.
- LOU Q, Bai R, Li L, Lu B, et al
Targeting ADAMTS4 aggravates myocardial ischemia-reperfusion injury by impairing
endothelial integrity and accelerating leukocyte infiltration.
Int J Cardiol. 2026;449:134195.
- LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
PCSK9 and residual risk after ST-elevation myocardial infarction.
Int J Cardiol. 2026;450:134231.
- LI S, Huo H, Zheng Y, Liu S, et al
Radiomics with native T1 mapping for contrast-free detection of acute and chronic
myocardial infarction: A multicenter study.
Int J Cardiol. 2026 Feb 17:134222. doi: 10.1016/j.ijcard.2026.134222.
J Am Coll Cardiol
- KRUMHOLZ HM
Women's Cardiovascular Health: From Inclusion to Design.
J Am Coll Cardiol. 2026;87:683-684.
- YONG CM, Spatz ES, Hayes SN
Sex Matters: Optimizing Cardiovascular Education and Training to Improve Women's
(and Men's) Heart Health.
J Am Coll Cardiol. 2026;87:742-745.
- HONIGBERG MC
Rethinking Cholesterol Management in Women: From Short-Term Risk Estimation to
Lifecourse Cardiovascular Health.
J Am Coll Cardiol. 2026;87:746-749.
- WARRAICH H
Tip of the Spear: The Cardiovascular Profession in the Age of AI.
J Am Coll Cardiol. 2026 Feb 18:S0735-1097(26)00292.
- PAREEK M, Johansen ND, Modin D, Pardo-Seco J, et al
High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease: A
Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD).
J Am Coll Cardiol. 2026 Feb 9:S0735-1097(25)10661.
- DOI T, Afzal S, Nordestgaard BG
Risk of Atherosclerotic Cardiovascular Disease in Familial Remnant Hyperlipidemia
(Dysbetalipoproteinemia) and Familial Hypercholesterolemia.
J Am Coll Cardiol. 2026 Feb 6:S0735-1097(26)00135.
- KRUMHOLZ HM
When Care Becomes Autonomous: AI and the Future of Cardiovascular Medicine.
J Am Coll Cardiol. 2026 Feb 18:S0735-1097(26)00300.
- ZHANG S, Wang Y, Wei J, Benmarhnia T, et al
Impact of Long-Term Cumulative Exposure to Wildfire Smoke PM(2.5) on
Cardiovascular Hospital Admissions Among Older Adults in the United States: A
Population-Based Cohort Study.
J Am Coll Cardiol. 2026 Feb 18:S0735-1097(25)10660.
- NEIRA M
PM(2.5) Spikes and Cardiovascular Mortality: Policy Priorities for Air Quality
Alerts.
J Am Coll Cardiol. 2026 Feb 6:S0735-1097(25)10410.
- MANGNER N, Beske RP, Hassager C, Jensen LO, et al
Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic
Shock in the DanGer Shock Trial.
J Am Coll Cardiol. 2026;87:704-719.
- GLAESER J, Lopez-Ayala P, Kellner C, Boeddinghaus J, et al
Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity
Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome
0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A
Prospective Multicente
J Am Coll Cardiol. 2026 Feb 10:S0735-1097(25)10588.
- YANG J, Yin P, Li M, Gao Y, et al
Long-Term Cardiovascular and Noncardiovascular Mortality After Acute Coronary
Syndrome: A Nationwide Competing-Risks Analysis of 1.56 Million Patients.
J Am Coll Cardiol. 2026 Feb 6:S0735-1097(25)10597.
- YANG Y, Deng J, Zhou P, Li P, et al
Short-Term PM(2.5) Exposure and Cardiovascular Mortality: A Global
Exposure-Response Analysis to Inform Alert Thresholds.
J Am Coll Cardiol. 2026 Feb 6:S0735-1097(25)10589.
- ABOU-KARAM R, Kim MS, Jemma Cho SM, Bitar F, et al
Polygenic Risk Based Detection and Treatment of Subclinical Coronary
Atherosclerosis in the PROACT Clinical Trials.
J Am Coll Cardiol. 2026 Feb 6:S0735-1097(25)10563.
- YANG C, Bai L, Wu S
Nonlinear Association Evidence and Optimal Alert Thresholds for Global Short-Term
PM(2.5) Exposure and Cardiovascular Mortality Risk.
J Am Coll Cardiol. 2026 Jan 22:S0735-1097(25)10475.
J Cardiovasc Pharmacol
- BIONDI-ZOCCAI G, Frati G, Booz GW
Closing the translational gap in cardiovascular artificial intelligence: from
drug discovery to evidence synthesis.
J Cardiovasc Pharmacol. 2026 Feb 18. doi: 10.1097/FJC.0000000000001808.
- GIORDANO S, Morello A, Biondi-Zoccai G, Corcione N, et al
When Phenotyping Is the Intervention: Personlized Treatment of Diffuse Coronary
Artery Disease.
J Cardiovasc Pharmacol. 2026 Feb 18. doi: 10.1097/FJC.0000000000001809.
- GIBSON CM, Escano AK, Hobe KD, Brody ER, et al
Safety and effectiveness of somatostatin and analogues on chest tube output after
coronary artery bypass grafting: A scoping review.
J Cardiovasc Pharmacol. 2026 Feb 19. doi: 10.1097/FJC.0000000000001810.
- WANG G, Luo Y, Song S, Li X, et al
Role of the Gut Microbiome in Modulating Interactions Between beta-Lactam
Antibiotics and Statins in Coronary Heart Disease.
J Cardiovasc Pharmacol. 2026 Feb 17. doi: 10.1097/FJC.0000000000001805.
J Clin Invest
- KAHLES F, Birkenfeld AL, Marx N
GLP-1 and the cardiovascular system.
J Clin Invest. 2026;136:e194748.
J Electrocardiol
- NI H, Wan X, Shi T, Gao Z, et al
A new and modified northern occlusion myocardial infarction pattern.
J Electrocardiol. 2026;95:154212.
J Thorac Cardiovasc Surg
- HASAN I, Bessette LG, Jacquemyn X, Wang Y, et al
Association of GLP-1 Inhibitors with Cardiovascular Outcomes in Patients
Undergoing Coronary Artery Bypass Surgery.
J Thorac Cardiovasc Surg. 2026 Feb 17:S0022-5223(26)00114.
N Engl J Med
- RAHHAL A, Al Hijji M, Arabi AR
Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2026;394:820.
- CHI KY, Mangalesh S, Nanna MG
Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2026;394:820-821.
- LLOP D, Turu M, Llop C
Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2026;394:821.
- GAMARDELLA M, Ciconte G, Pappone C
Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2026;394:822.
- ZIEMINSKI JJ, Bell MR
Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2026;394:822-823.
- IBANEZ B, Latini R, Rossello X
Beta-Blockers after Myocardial Infarction. Reply.
N Engl J Med. 2026;394:823-824.
- MUNKHAUGEN J, Atar D, Prescott E
Beta-Blockers after Myocardial Infarction. Reply.
N Engl J Med. 2026;394:824-825.
- CEREDA A, Stracqualursi M, Lucreziotti S
Beta-Blockers after Myocardial Infarction.
N Engl J Med. 2026;394:821-822.
PLoS One
- FU W, Lin J, Lin W, Zeng K, et al
FNDC5/Irisin-dependent renoprotection of resistance training in myocardial
infarction-induced Type 2 cardiorenal syndrome.
PLoS One. 2026;21:e0342468.
Proc Natl Acad Sci U S A
- XU Y, Chen Y, Wang Y, Yang Z, et al
Artificially constructed collagen-targeting receptors on mesenchymal stromal
cells promote anoikis resistance and tissue repair.
Proc Natl Acad Sci U S A. 2026;123:e2525881123.
Prog Cardiovasc Dis
- PEI H, He L, Wang S, Mo C, et al
Association between gout and cardiovascular disease: A register-based cohort
study.
Prog Cardiovasc Dis. 2026 Feb 16:S0033-0620(26)00008.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016